Table 2.

Goal directed medical therapy analysis between patients with and without LVT recurrence.

	Total	Recurrence	No recurrence	p-value
	n = 87	n = 9	n = 78
ACE inhibitor/ARBs, n (%)				0.48
Yes	56 (64.4 %)	7 (77.8 %)	49 (62.8 %)
No	31 (35.6 %)	2 (22.2 %)	29 (37.2 %)
Spironolactone, n (%)				NS
Yes	10 (11.5 %)	1 (11.1 %)	9 (11.5 %)
No	77 (88.5 %)	8 (88.9 %)	69 (88.5 %)
Beta Blocker, n (%)				NS
Yes	68 (78.2 %)	7 (77.8 %)	61 (78.2 %)
No	19 (21.8 %)	2 (22.2 %)	17 (21.8 %)
Greater than 2 GDMT drugs				0.73
Yes	49 (56.3 %)	6 (66.7 %)	43 (55.1 %)
No	38 (43.7 %)	3 (33.3 %)	35 (44.9 %)